Strides Pharma Science Limited is a leading Indian pharmaceutical company headquartered in Bangalore, Karnataka. It was established in 1990 as the domestic formulation business of Strides Arcolab Limited. In 2006, the company became an independent entity and was renamed Strides Pharma Science Limited.

The company develops, manufactures, and markets pharmaceutical products globally. It focuses on various therapeutic segments, including anti-infectives, central nervous system, cardiovascular, and oncology. Strides Pharma Science offers a wide range of products, including tablets, capsules, injectables, and topicals.

It also produces specialty products such as soft gelatin capsules and oral thin films. Strides Pharma Science has a significant global presence and operates in over 100 countries. The company has manufacturing facilities in India, Europe, Africa, and the Asia-Pacific region.

It owns many subsidiaries, including Strides Pharma Global Pte Ltd in Singapore and Strides Pharma UK Ltd in the United Kingdom. Additionally, the company has formed various partnerships and joint ventures with multinational pharmaceutical companies to expand its market reach and improve its product offerings. In terms of market position, Strides Pharma Science is one of the top pharmaceutical companies in India.

It has a strong international presence and has established itself as a reliable and trusted supplier of high-quality pharmaceutical products. The company has been consistently growing its global sales, and its robust distribution network allows it to cater to diverse markets. In recent years, Strides Pharma Science has focused on expanding its presence in regulated markets, particularly the United States.

It has received several regulatory approvals from the US Food and Drug Administration (FDA) for its manufacturing facilities and products. The company has also undertaken strategic acquisitions and divestments to optimize its product portfolio and drive growth. As of the latest information available, Strides Pharma Science continues to evolve as a global pharmaceutical company with a strong emphasis on research and development, quality manufacturing, and regulatory compliance.

It remains committed to providing affordable and accessible healthcare solutions across the globe